3Tenover FC,Rasheed JK.Genetic methods for detecting antibacterial and antiviral resistance genes.In:Murray PR,Baron EJ,Pfaller MA,Tenover FC,Yolken RH,eds.Murray of clinical microbiology.Washington,DC:American Society for Microbiology,1999:1578～1592.
5National Committee for Clinical Laboratory Standards.Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically.Approved standard M7-A5.Wayne.Pennsylvania:National Committee for Clinical Laboratory Standards,2000.
6National Committee for Clinical Laboratory Standards.Performance standards for antimicrobial disk susceptibility testing.Approved standard M2-A7. Wayne..Pennsylvania:National Committee for Clinical Laboratory Standards,2000.
7Jorgensen MH,Ferraro MJ.Antimicrobial susecptibility testing;special needs for fastidious organisms and difficult-detect resistance mechanisms[J].Clinical Infection Diseases.2000;30:799～808.
8Doern GV,Jones RN,Pfaller MA,Kugler K,the SENTRY Participants Group.Haemophilus infuenzae and Moraxella catarhalis form patients with community-acquired respiratcry tract infections:antimicrobial susceptibility pattrtns from the SENTRY antimicrobial survillance program (United States and Canada.1997)[J].Antimicrob Agents Chemother,1999:43:385～389.
9Centers for Disease Control and Prevention.1998 Guidelines for treatment of sexually transmitted disease[J].MMWR Morb Mortal Wkly Rep,1998:47(RR-1):59～69.
10Buter JC,Hofmann MS,et al.The continued emergence of drug resistant Streptococcus pneumoniae in the United States:an update from the Centers for Disease Control and Prevention's pneumococcal sentinel surveillance system[J].J Infect Dis,1996:174:986～993.
3Kim SN ,Kim SW ,Choi IH ,et al . High incidence of multidrug resistant streptococcus pneumoniae in South Korea [J].Microbial Drug Resistance ,1996;2:401.
